|
Press Releases |
|
![](/images/company/astarA.jpg) |
|
Tuesday, December 6, 2022 |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
Thursday, June 2, 2022 |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
more info >> |
|
Thursday, September 30, 2021 |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
Friday, July 31, 2020 |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
Friday, July 24, 2020 |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
Tuesday, October 22, 2019 |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
Monday, October 21, 2019 |
|
富士通・シンガポール科学技術庁・Singapore Management University、「デジタルアニーラ」とディープラーニング技術を活用したプロジェクトを開始 |
富士通株式会社とシンガポール科学技術庁のハイパフォーマンスコンピューティング研究所(Institute of High Performance Computing)、およびSingapore Management Universityはこのたび、「FUJITSU Quantum-Inspired Computing Digital Annealer」とディープラーニング技術を活用したデジタルプラットフォーム実装プロジェクトを開始します。 more info >> |
|
Friday, June 28, 2019 |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery and development. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Domino's Pizza Inc. Is Being Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations
Jul 26, 2024 23:30 HKT/SGT
|
|
|
CORRECTION FROM SOURCE: Doubleview Reports Maiden Mineral Resource Estimate
Jul 26, 2024 21:00 HKT/SGT
|
|
|
CITIC Resources Announces its 2024 Interim Results
Jul 26, 2024 20:43 HKT/SGT
|
|
|
中信資源公布2024年度中期業績 收入大幅增長93.1%至約39.4億港元
Jul 26, 2024 20:29 HKT/SGT
|
|
|
OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology
Jul 26, 2024 20:05 HKT/SGT
|
|
|
VCI Global Enters into AI Computing Alliance (AICA) Led by Enlight Corporation and Supermicro
Jul 26, 2024 20:00 HKT/SGT
|
|
|
中信资源公布2024年度中期业绩 收入大幅增长93.1%至约39.4亿港元
Jul 26, 2024 19:57 HKT/SGT
|
|
|
華邦科技集團成員及策略夥伴攬獲「專業金融機構服務大獎2024」兩項殊榮 [更新版]
Jul 26, 2024 17:42 HKT/SGT
|
|
|
华邦科技集团成员及策略伙伴揽获“专业金融机构服务大奖2024”两项殊荣[更新版]
Jul 26, 2024 17:18 HKT/SGT
|
|
|
DOCOMO and NTT Com Jointly Demonstrate Practicality of DOCOMO's New Multi-platform Cloud-rendering Technology
Jul 26, 2024 17:05 JST
|
|
|
Kucingko Berhad Debuts on ACE Market with Clawsome Opening Price of RM0.805
Jul 26, 2024 16:00: JST
|
|
|
Kucingko Berhad Debuts on ACE Market with Clawsome Opening Price of RM0.805
Jul 26, 2024 15:00 HKT/SGT
|
|
|
華邦科技旗下公司攬獲「專業金融機構服務大獎2024」兩項殊榮
Jul 26, 2024 13:26 HKT/SGT
|
|
|
华邦科技旗下公司揽获“专业金融机构服务大奖2024”两项殊荣
Jul 26, 2024 13:15 HKT/SGT
|
|
|
British Veterinary Association Ends Opposition to Vegan Diets for Dogs
Jul 26, 2024 02:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|